QUCY

Mainz Biomed N.V. Ordinary Shares

0.47

USD

QUCY Earnings Reports

Positive Surprise Ratio

No Data Available for QUCY

Next Report

Next Week

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$2.04

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Mainz Biomed N.V. Ordinary Shares earnings per share and revenue

On --, QUCY reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -2.04 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Biofrontera Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

$0.19

Actual

$0.50

Surprise

+151.38%

Abivax SA - ADR

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$1.52

Actual

-$1.02

Surprise

+32.82%

Alvotech Ordinary Shares

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.37

Surprise

-706.10%

Eton Pharmaceutcials, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

$0.09

Actual

$0.05

Surprise

-45.53%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

Cellectis S.A. - ADR

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.26

Actual

-$0.26

Surprise

+1.78%

Eledon Pharmaceuticals, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.20

Actual

-$0.10

Surprise

+51.78%

Artiva Biotherapeutics, Inc. Common Stock

Report Date

Mar 30, 2026 For Q4 25

Estimate

-$0.84

Actual

Surprise

Milestone Pharmaceuticals Inc. Common Shares

Report Date

Mar 20, 2026 For Q4 25

Estimate

-$0.16

Actual

-$0.16

Surprise

+1.96%

Spruce Biosciences, Inc. Common Stock

Report Date

Apr 13, 2026 For Q4 25

Estimate

-$8.14

Actual

Surprise

FAQ

What were Mainz Biomed N.V. Ordinary Shares's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Mainz Biomed N.V. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Mainz Biomed N.V. Ordinary Shares's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Mainz Biomed N.V. Ordinary Shares expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for Mainz Biomed N.V. Ordinary Shares's next earnings report?

Based on -- analysts, Mainz Biomed N.V. Ordinary Shares is expected to report EPS of -$2.04 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.